Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76751 - 76775 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tamoxifen	Approved Investigational	CYP27B1	1594	downregulated	Tamoxifen results in decreased expression of CYP27B1 mRNA	12q14.1	A24383
Tamoxifen	Approved Investigational	CYP3A4	1576	upregulated	Tamoxifen results in increased expression of CYP3A4 mRNA	7q22.1	A17277
Tamoxifen	Approved Investigational	DAG1	1605	upregulated	Tamoxifen results in increased expression of DAG1 mRNA	3p21.31	A3616
Tamoxifen	Approved Investigational	DDIT3	1649	upregulated	Tamoxifen results in increased expression of DDIT3 mRNA	12q13.3	A3616
Tamoxifen	Approved Investigational	DDX42	11325	upregulated	Tamoxifen results in increased expression of DDX42 mRNA	17q23.3	A3616
Tamoxifen	Approved Investigational	DEK	7913	downregulated	Tamoxifen results in decreased expression of DEK mRNA	6p22.3	A21240
Tamoxifen	Approved Investigational	DHFR	1719	upregulated	Tamoxifen results in increased expression of DHFR mRNA	5q14.1	A24383
Tamoxifen	Approved Investigational	DHX38	9785	downregulated	Tamoxifen results in decreased expression of DHX38 mRNA	16q22.2	A24383
Tamoxifen	Approved Investigational	DKK4	27121	downregulated	Tamoxifen results in decreased expression of DKK4 mRNA	8p11.21	A24383
Tamoxifen	Approved Investigational	DMBT1	1755	upregulated	Tamoxifen results in increased expression of DMBT1 mRNA	10q26.13	A22734
Tamoxifen	Approved Investigational	DNMT3B	1789	upregulated	Tamoxifen results in increased expression of DNMT3B mRNA alternative form	20q11.21	A24387
Tamoxifen	Approved Investigational	DRD5	1816	upregulated	Tamoxifen results in increased expression of DRD5 mRNA	4p16.1	A21112
Tamoxifen	Approved Investigational	DST	667	upregulated	Tamoxifen results in increased expression of DST mRNA	6p12.1	A21116
Tamoxifen	Approved Investigational	DUSP5	1847	upregulated	Tamoxifen results in increased expression of DUSP5 mRNA	10q25.2	A3616
Tamoxifen	Approved Investigational	E2F1	1869	downregulated	Tamoxifen results in decreased expression of E2F1 mRNA	20q11.22	A24383
Tamoxifen	Approved Investigational	E2F1	1869	upregulated	Tamoxifen results in increased expression of E2F1 mRNA	20q11.22	A22730
Tamoxifen	Approved Investigational	ECE1	1889	upregulated	Tamoxifen results in increased expression of ECE1 mRNA	1p36.12	A21245
Tamoxifen	Approved Investigational	EDN1	1906	upregulated	Tamoxifen results in increased expression of EDN1 mRNA	6p24.1	A21245
Tamoxifen	Approved Investigational	EDNRA	1909	upregulated	Tamoxifen results in increased expression of EDNRA mRNA	4q31.22-q31.23	A21245
Tamoxifen	Approved Investigational	EGFR	1956	upregulated	Tamoxifen results in increased expression of EGFR mRNA	7p11.2	A21246
Tamoxifen	Approved Investigational	EHHADH	1962	downregulated	Tamoxifen results in decreased expression of EHHADH mRNA	3q27.2	A20645
Tamoxifen	Approved Investigational	EIF5	1983	upregulated	Tamoxifen results in increased expression of EIF5 mRNA	14q32.32	A3616
Tamoxifen	Approved Investigational	ESR1	2099	downregulated	Tamoxifen results in decreased expression of ESR1 mRNA	6q25.1-q25.2	A24385
Tamoxifen	Approved Investigational	ESR1	2099	upregulated	Tamoxifen results in increased expression of ESR1 mRNA	6q25.1-q25.2	A13620 A21264
Tamoxifen	Approved Investigational	ESRRA	2101	upregulated	Tamoxifen results in increased expression of ESRRA mRNA	11q13.1	A21141

Displaying entries 76751 - 76775 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability